Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.01−0.02 (-1.94%)
Close on Nov 17, 2026Market cap $176.01MP/E –Yield –
Palisade Bio total assets
Total assets on the balance sheet at the end of each period.
Palisade Bio's total assets was $127.32M at Jun 30, 2026. For fiscal 2025 it was $134.34M, up 1134.8% from the year before. Over ten years it grew 24.6% a year on average. The highest annual figure on record is $134.34M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $134.34M | +1134.8% |
| FY2024 | Dec 31, 2024 | $10.88M | -22.6% |
| FY2023 | Dec 31, 2023 | $14.05M | -10.9% |
| FY2022 | Dec 31, 2022 | $15.76M | +26.0% |
| FY2021 | Dec 31, 2021 | $12.51M | +314.4% |
| FY2020 | Dec 31, 2020 | $3.02M | -54.1% |
| FY2019 | Dec 31, 2019 | $6.58M | -14.3% |
| FY2018 | Dec 31, 2018 | $7.68M | -44.7% |
| FY2017 | Dec 31, 2017 | $13.88M | -38.6% |
| FY2016 | Dec 31, 2016 | $22.60M | +51.2% |
| FY2015 | Dec 31, 2015 | $14.95M | -49.9% |
| FY2014 | Dec 31, 2014 | $29.84M | +53.7% |
| FY2013 | Dec 31, 2013 | $19.41M | +121.9% |
| FY2012 | Dec 31, 2012 | $8.75M | +114.1% |
| FY2011 | Dec 31, 2011 | $4.09M | -61.4% |
| FY2010 | Dec 31, 2010 | $10.59M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $127.32M | +1809.6% |
| Q1 FY2026 | Mar 31, 2026 | $133.32M | +1527.8% |
| Q4 FY2025 | Dec 31, 2025 | $134.34M | +1134.8% |
| Q3 FY2025 | Sep 30, 2025 | $6.97M | -25.3% |
| Q2 FY2025 | Jun 30, 2025 | $6.67M | -48.2% |
| Q1 FY2025 | Mar 31, 2025 | $8.19M | -35.3% |
| Q4 FY2024 | Dec 31, 2024 | $10.88M | -22.6% |
| Q3 FY2024 | Sep 30, 2024 | $9.34M | -45.3% |
| Q2 FY2024 | Jun 30, 2024 | $12.87M | -29.6% |
| Q1 FY2024 | Mar 31, 2024 | $12.65M | -17.1% |
| Q4 FY2023 | Dec 31, 2023 | $14.05M | -10.9% |
| Q3 FY2023 | Sep 30, 2023 | $17.07M | +4.9% |
| Q2 FY2023 | Jun 30, 2023 | $18.29M | +134.3% |
| Q1 FY2023 | Mar 31, 2023 | $15.26M | +82.8% |
| Q4 FY2022 | Dec 31, 2022 | $15.76M | +26.0% |
| Q3 FY2022 | Sep 30, 2022 | $16.27M | -0.0% |
| Q2 FY2022 | Jun 30, 2022 | $7.81M | -47.8% |
| Q1 FY2022 | Mar 31, 2022 | $8.35M | -6.3% |
| Q4 FY2021 | Dec 31, 2021 | $12.51M | +314.4% |
| Q3 FY2021 | Sep 30, 2021 | $16.27M | +7.3% |
| Q2 FY2021 | Jun 30, 2021 | $14.95M | -12.6% |
| Q1 FY2021 | Mar 31, 2021 | $8.91M | -21.5% |
| Q4 FY2020 | Dec 31, 2020 | $3.02M | -54.1% |
| Q3 FY2020 | Sep 30, 2020 | $15.17M | +69.6% |
| Q2 FY2020 | Jun 30, 2020 | $17.10M | +385.6% |
| Q1 FY2020 | Mar 31, 2020 | $11.36M | +110.2% |
| Q4 FY2019 | Dec 31, 2019 | $6.58M | -14.3% |
| Q3 FY2019 | Sep 30, 2019 | $8.94M | +15.8% |
| Q2 FY2019 | Jun 30, 2019 | $3.52M | -61.9% |
| Q1 FY2019 | Mar 31, 2019 | $5.41M | -53.2% |
| Q4 FY2018 | Dec 31, 2018 | $7.68M | -44.7% |
| Q3 FY2018 | Sep 30, 2018 | $7.72M | -52.3% |
| Q2 FY2018 | Jun 30, 2018 | $9.23M | -30.4% |
| Q1 FY2018 | Mar 31, 2018 | $11.55M | -38.3% |
| Q4 FY2017 | Dec 31, 2017 | $13.88M | -38.6% |
| Q3 FY2017 | Sep 30, 2017 | $16.19M | +91.6% |
| Q2 FY2017 | Jun 30, 2017 | $13.27M | – |
| Q1 FY2017 | Mar 31, 2017 | $18.73M | – |
| Q4 FY2016 | Dec 31, 2016 | $22.60M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.45M | – |
See a number that looks wrong?